Selecting an Antidepressant for Use in a Patient with Epilepsy
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 18 (2) , 125-133
- https://doi.org/10.2165/00002018-199818020-00004
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodesEuropean Neuropsychopharmacology, 1997
- Seizure length during ECTThe British Journal of Psychiatry, 1996
- ECG Lead aVR Versus QRS Interval in Predicting Seizures and Arrhythmias in Acute Tricyclic Antidepressant ToxicityAnnals of Emergency Medicine, 1995
- Cyclic Antidepressant Toxicity in Children and AdolescentsThe Journal of Clinical Pharmacology, 1995
- Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s)Life Sciences, 1993
- Fluvoxamine: an antidepressant with low (or no) epileptogenic effectThe Lancet, 1990
- QRS interval in tricyclic antidepressant overdosage: Inaccuracy as a toxicity indicator in emergency settingsAnnals of Emergency Medicine, 1987
- Paroxetine and the electroencephalogramJournal of Psychopharmacology, 1987
- A Guarded Endorsement for Shock TherapyScience, 1985
- CLINICAL COURSE AND PROGNOSIS OF TEMPORAL LOBE EPILEPSY: A Survey of 666 PatientsBrain, 1971